BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 22623680)

  • 1. A new mechanism for transmissible prion diseases.
    Makarava N; Kovacs GG; Savtchenko R; Alexeeva I; Ostapchenko VG; Budka H; Rohwer RG; Baskakov IV
    J Neurosci; 2012 May; 32(21):7345-55. PubMed ID: 22623680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genesis of mammalian prions: from non-infectious amyloid fibrils to a transmissible prion disease.
    Makarava N; Kovacs GG; Savtchenko R; Alexeeva I; Budka H; Rohwer RG; Baskakov IV
    PLoS Pathog; 2011 Dec; 7(12):e1002419. PubMed ID: 22144901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two alternative pathways for generating transmissible prion disease de novo.
    Makarava N; Savtchenko R; Baskakov IV
    Acta Neuropathol Commun; 2015 Nov; 3():69. PubMed ID: 26556038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective amplification of classical and atypical prions using modified protein misfolding cyclic amplification.
    Makarava N; Savtchenko R; Baskakov IV
    J Biol Chem; 2013 Jan; 288(1):33-41. PubMed ID: 23168413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Molecular Insight into Mechanism of Evolution of Mammalian Synthetic Prions.
    Makarava N; Savtchenko R; Alexeeva I; Rohwer RG; Baskakov IV
    Am J Pathol; 2016 Apr; 186(4):1006-14. PubMed ID: 26873446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preserving prion strain identity upon replication of prions in vitro using recombinant prion protein.
    Makarava N; Savtchenko R; Lasch P; Beekes M; Baskakov IV
    Acta Neuropathol Commun; 2018 Sep; 6(1):92. PubMed ID: 30208966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genesis of tramsmissible protein states via deformed templating.
    Makarava N; Baskakov IV
    Prion; 2012 Jul; 6(3):252-5. PubMed ID: 22561163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical and classical forms of the disease-associated state of the prion protein exhibit distinct neuronal tropism, deposition patterns, and lesion profiles.
    Kovacs GG; Makarava N; Savtchenko R; Baskakov IV
    Am J Pathol; 2013 Nov; 183(5):1539-1547. PubMed ID: 24012784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PrP P102L and Nearby Lysine Mutations Promote Spontaneous
    Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo generation of infectious prions in vitro produces a new disease phenotype.
    Barria MA; Mukherjee A; Gonzalez-Romero D; Morales R; Soto C
    PLoS Pathog; 2009 May; 5(5):e1000421. PubMed ID: 19436715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
    Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
    J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant prion protein induces a new transmissible prion disease in wild-type animals.
    Makarava N; Kovacs GG; Bocharova O; Savtchenko R; Alexeeva I; Budka H; Rohwer RG; Baskakov IV
    Acta Neuropathol; 2010 Feb; 119(2):177-87. PubMed ID: 20052481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocatalytic self-propagation of misfolded prion protein.
    Bieschke J; Weber P; Sarafoff N; Beekes M; Giese A; Kretzschmar H
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12207-11. PubMed ID: 15297610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct structures of scrapie prion protein (PrPSc)-seeded versus spontaneous recombinant prion protein fibrils revealed by hydrogen/deuterium exchange.
    Smirnovas V; Kim JI; Lu X; Atarashi R; Caughey B; Surewicz WK
    J Biol Chem; 2009 Sep; 284(36):24233-41. PubMed ID: 19596861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity.
    Katorcha E; Makarava N; Savtchenko R; D'Azzo A; Baskakov IV
    PLoS Pathog; 2014 Sep; 10(9):e1004366. PubMed ID: 25211026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pressure-assisted dissociation and degradation of "proteinase K-resistant" fibrils prepared by seeding with scrapie-infected hamster prion protein.
    Akasaka K; Maeno A; Murayama T; Tachibana H; Fujita Y; Yamanaka H; Nishida N; Atarashi R
    Prion; 2014; 8(4):314-8. PubMed ID: 25482603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charge neutralization of the central lysine cluster in prion protein (PrP) promotes PrP(Sc)-like folding of recombinant PrP amyloids.
    Groveman BR; Kraus A; Raymond LD; Dolan MA; Anson KJ; Dorward DW; Caughey B
    J Biol Chem; 2015 Jan; 290(2):1119-28. PubMed ID: 25416779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion infectivity is encoded exclusively within the structure of proteinase K-resistant fragments of synthetically generated recombinant PrP
    Wang F; Wang X; Abskharon R; Ma J
    Acta Neuropathol Commun; 2018 Apr; 6(1):30. PubMed ID: 29699569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in prion replication environment cause prion strain mutation.
    Gonzalez-Montalban N; Lee YJ; Makarava N; Savtchenko R; Baskakov IV
    FASEB J; 2013 Sep; 27(9):3702-10. PubMed ID: 23729586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.